Eye drops, inhalers targeted in latest round of FDA CBD warnings

Five more CBD manufacturers have gotten warning letters from the U.S. Food and Drug Administration for making illegal medical claims, with the agency raising special alarm Tuesday because of how some of the products are taken — inhaled or dropped in the eyes.